NaukriHub-Job Search Site


Submit Resume
Google
Indian Industry

Scope of Biotechnology Sector

Biotechnology Sector: Current Scenario
In 1978, Circa was the only Indian biotech company that used to manufacture fermentations and enzyme products. Today, Indian biotech sector comprises of more than 280 companies, generating revenues of about US$ 1.5 billion. Indian biotech industry comprises of clinical research, new drug discovery, bioinformatics, contract R&D, biopharmaceuticals, etc.

In India, Bangalore has emerged as the largest biotech hub with a total annual sales revenue of about Rs. 1400 crore. There are about 175 companies working in the diverse areas of bioagri, bioindustrial, bioservices, nutraceutical, biopharma, bioinformatics, herbal products and biosuppliers.
With the supporting policy framework, biogenerics or biosimilars, bio manufacturing, stem cells and regenerative medicine have been identified as areas of strategic importance. Biotech sector achievements are as follows:

  • Biotech Industry has 37.42% growth rate per annum
  • Biotech industry has reached US$ 1.5 billion
  • Bioservices has reached US$ 160 million
  • Bioagri sector has crossed US$ 130 million
  • Biopharma has reached US$ 1billion

    Biotechnology Sector: Future Scenario
    Globally, Indian biotech industry has emerged as the manufacturer of novel and proprietary biotech products. The factors behind this success are specialized human resource, internationally benchmarked infrastructure and national biotechnology strategy.

    With 208 biotech companies and 180 bio-suppliers, Indian biotech industry is worth US$ 1.45 billion. Bio-partnering and co-developing technologies with American and Chinese companies will increase the scope of R&D in India.

    Emerging investment opportunities and increasing global visibility has forced Indian biotech companies to develop business models, improve product commercialization and make strong market position.

    Infrastructure for R&D in protein engineering, molecular studies, immunological studies and drug designing is also developing. There is lot of scope in biogenerics sector as many biological drugs are going off-patent in coming years.

    Regulatory framework in association with strong biomanufacturing skills will help in getting approval for generic versions of biologicals e.g. GCSF, insulin, Hep B vaccine, etc.


  • Indian Industry
    Know the business of india with
    detailed analysis
    Click Here
     
    HR Chronicle
    Read the latest articles on
    Jobs by Country
    more..
    Career Institutes
    Want to know about professional career institutes.
    Recruitment Consultants
    Want to know about recruitment consultants in India
    Career Development
    Are you in need of a
    councillor to help you in
    choosing the right career?




     
     
     
     
    Resources in India